SAMSRITA LABS LIMITED (SAMSRITA.BO)
INR 24.14
(0.0%)
INR 24.14
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - INR | 0.0% |
| 2022 | - INR | 0.0% |
| 2021 | - INR | 0.0% |
| 2020 | - INR | 0.0% |
| 2019 | - INR | 0.0% |
| 2018 | - INR | 0.0% |
| 2017 | - INR | 0.0% |
| 2016 | - INR | 0.0% |
| 2015 | - INR | 0.0% |
| 2014 | - INR | 0.0% |
| 2013 | - INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 0.0% |
| 2023 Q3 | - INR | 0.0% |
| 2023 Q1 | - INR | 0.0% |
| 2023 Q4 | - INR | 0.0% |
| 2023 FY | - INR | 0.0% |
| 2023 Q2 | - INR | 0.0% |
| 2022 Q1 | - INR | 0.0% |
| 2022 Q2 | - INR | 0.0% |
| 2022 Q4 | - INR | 0.0% |
| 2022 FY | - INR | 0.0% |
| 2022 Q3 | - INR | 0.0% |
| 2021 FY | - INR | 0.0% |
| 2021 Q4 | - INR | 0.0% |
| 2021 Q3 | - INR | 0.0% |
| 2021 Q2 | - INR | 0.0% |
| 2021 Q1 | - INR | 0.0% |
| 2020 FY | - INR | 0.0% |
| 2020 Q3 | - INR | 0.0% |
| 2020 Q2 | - INR | 0.0% |
| 2020 Q1 | - INR | 0.0% |
| 2020 Q4 | - INR | 0.0% |
| 2019 Q2 | - INR | 0.0% |
| 2019 Q3 | - INR | 0.0% |
| 2019 FY | - INR | 0.0% |
| 2019 Q1 | - INR | 0.0% |
| 2019 Q4 | - INR | 0.0% |
| 2018 FY | - INR | 0.0% |
| 2017 FY | - INR | 0.0% |
| 2016 Q2 | - INR | 0.0% |
| 2016 Q3 | - INR | 0.0% |
| 2016 Q4 | 65 Million INR | 0.0% |
| 2016 FY | - INR | 0.0% |
| 2015 FY | - INR | 0.0% |
| 2014 FY | - INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2014 Q4 | - INR | 0.0% |
| 2013 FY | - INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 100.0% |
| Biocon Limited | 129.32 Billion INR | 100.0% |
| Blue Jet Healthcare Limited | 3.79 Million INR | 100.0% |
| Concord Biotech Limited | 18.87 Million INR | 100.0% |
| Dishman Carbogen Amcis Limited | 2.45 Billion INR | 100.0% |
| FERMENTA BIOTECH LIMITED | 425.36 Million INR | 100.0% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | NaN% |
| Lyka Labs Limited | 429.06 Million INR | 100.0% |
| Panacea Biotec Limited | 209.9 Million INR | 100.0% |
| Servoteach Industries Limited | 5059.00 INR | 100.0% |
| SMS Lifesciences India Limited | 331.45 Million INR | 100.0% |
| Supriya Lifescience Limited | 50.2 Million INR | 100.0% |
| Syngene International Limited | 1 Billion INR | 100.0% |
| TAKE Solutions Limited | 7.5 Million INR | 100.0% |
| Titan Biotech Limited | 4.53 Million INR | 100.0% |
| Transgene Biotek Limited | 50.79 Million INR | 100.0% |
| Vanta Bioscience Limited | 488.01 Million INR | 100.0% |